This federal contract award, valued at $4,950.42, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,556,198,821 units of Heparin Sodium 5,000 Unit/0.5 mL injections. This is a firm fixed-price delivery order contract with a completion date of February 9, 2022.
Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which also holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Additionally, Cencora, Inc. maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
The contract award does not have a set-aside designation, indicating open competition. This award demonstrates Amerisourcebergen's capability to supply essential pharmaceutical products to various government agencies, including the DLA, which oversees the procurement of medical commodities for the Department of Defense and other federal healthcare programs.